5 Recruiting Studies Using Cemdisiran
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cemdisiran
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
📍 HonorHealth Neurology 2018 — Scottsdale, Arizona
Generalized Myasthenia Gravis
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
📍 The Oncology Institute of Hope & Innovation — Whittier, California
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
📍 Hospital das Clinicas da FMRP USP — Ribeirão Preto, São Paulo
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
📍 Barnet Dulaney Perkins Eye Center-Ophthamalogy — Chandler, Arizona
Age-related Macular Degeneration (AMD)
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
📍 Toronto General Hospital — Toronto, Ontario
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔